Author Correction: Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis

QR Code

Author Correction: Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis

Saved in:

Bibliographic Details
Main Authors:	Philip A. Waghorn, Diego S. Ferreira, Derek J. Erstad, Nicholas J. Rotile, Ricard Masia, Chloe M. Jones, Chuantao Tu, Mozhdeh Sojoodi, Yin-ching I. Chen, Franklin Schlerman, Jeremy Wellen, Robert V. P. Martinez, Kenneth K. Tanabe, Bryan C. Fuchs, Peter Caravan
Format:	article
Language:	EN
Published:	Nature Portfolio 2021
Subjects:	Medicine R Science Q
Online Access:	https://doaj.org/article/5dff62519d184cbbbad8e11434fc02ef
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis
by: Philip A. Waghorn, et al.
Published: (2021)

Quantitative MRI-based radiomics for noninvasively predicting molecular subtypes and survival in glioma patients
by: Jing Yan, et al.
Published: (2021)

Statins in Non-alcoholic Steatohepatitis
by: Jose D. Torres-Peña, et al.
Published: (2021)

Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates
by: Philippe Garteiser, et al.
Published: (2021)

Preliminary pilot fMRI study of neuropostural optimization with a noninvasive asymmetric radioelectric brain stimulation protocol in functional dysmetria
by: Mura M, et al.
Published: (2012)

Association between Equol Production Status and Nonalcoholic Steatohepatitis
by: Takemi Akahane, et al.
Published: (2021)

Cathepsin D regulates lipid metabolism in murine steatohepatitis
by: Tom Houben, et al.
Published: (2017)

Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
by: Justine Gillard, et al.
Published: (2022)

Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mice
by: Joost Willebrords, et al.
Published: (2017)

NEALKOHOLNI STEATOHEPATITIS PRI OTROKU − PRAKTIČNI PRISTOP S PREDSTAVITVIJO PRIMERA
by: Ana Šinkovec, et al.
Published: (2021)

Recent advances in noninvasive glucose monitoring
by: So CF, et al.
Published: (2012)

Loss of SNORA73 reprograms cellular metabolism and protects against steatohepatitis
by: Arthur C. Sletten, et al.
Published: (2021)

The development of nonalcoholic steatohepatitis is subjected to breeder dependent variation in guinea pigs
by: D. H. Ipsen, et al.
Published: (2021)

MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model
by: Hiroki Sakamoto, et al.
Published: (2021)

β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model
by: Zigmond E, et al.
Published: (2014)

Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study
by: Kawanaka M, et al.
Published: (2013)

NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN − A PRACTICAL APPROACH WITH CASE REPORT
by: Ana Šinkovec, et al.
Published: (2021)

Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles
by: Cui Y, et al.
Published: (2016)

Advances in the Noninvasive Diagnosis of Dry Eye Disease
by: Luca Di Cello, et al.
Published: (2021)

Noninvasive intraocular pressure monitoring: current insights
by: De Smedt S
Published: (2015)

Noninvasive Prototype for Type 2 Diabetes Detection
by: Javier Ferney Castillo García, et al.
Published: (2021)

Drug-device pairing in noninvasive brain stimulation
by: Alexander Rotenberg
Published: (2021)

MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis
by: Huang J, et al.
Published: (2021)

Clodronate, an inhibitor of the vesicular nucleotide transporter, ameliorates steatohepatitis and acute liver injury
by: Nao Hasuzawa, et al.
Published: (2021)

Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosis
by: Yadi Li, et al.
Published: (2021)

Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study
by: Alia Hadefi, et al.
Published: (2021)

Cargo proteins in extracellular vesicles: potential for novel therapeutics in non-alcoholic steatohepatitis
by: Jimin Kim, et al.
Published: (2021)

Noninvasive transcranial classification of stroke using a portable eddy current damping sensor
by: Shane Shahrestani, et al.
Published: (2021)

Noninvasive ultrasound stimulation of the spleen to treat inflammatory arthritis
by: Daniel P. Zachs, et al.
Published: (2019)

Noninvasive thrombectomy of graft by nano-magnetic ablating particles
by: Abbas Moghanizadeh, et al.
Published: (2021)

Administration of inhaled medications during noninvasive ventilation and/or tracheostomy
by: Kathleen ASTURIAN, et al.
Published: (2020)

Noninvasive sub-organ ultrasound stimulation for targeted neuromodulation
by: Victoria Cotero, et al.
Published: (2019)

Differentiation between chalazion and sebaceous carcinoma by noninvasive meibography
by: Nemoto Y, et al.
Published: (2014)

Flexible and Printed Microwave Plasmonic Sensor for Noninvasive Measurement
by: Li Hui Dai, et al.
Published: (2020)

Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes.
by: Kristin Alexandra Dayton, et al.
Published: (2021)

CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis
by: Guangyong Sun, et al.
Published: (2021)

The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017
by: Mimi Zhai, et al.
Published: (2021)

Author Correction: Loss of SNORA73 reprograms cellular metabolism and protects against steatohepatitis
by: Arthur C. Sletten, et al.
Published: (2021)

Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
by: Daniel Cabrera, et al.
Published: (2017)

Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice
by: Kook Hwan Kim, et al.
Published: (2018)